Diadema Partners »

Kodiak Sciences shares owned by Diadema Partners

Quarter-by-quarter ownership of Kodiak Sciences (KOD) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Kodiak Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kodiak Sciences held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kodiak Sciences by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $473k 29k 16.37

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Kodiak Sciences

Baker Bros. Advisors
BlackRock
Point72 Asset Management
Vanguard Group
Adage Capital Partners GP
ICONIQ Capital
TCG Crossover Management
Silverarc Capital Management
Acadian Asset Management
State Street Corporation
Geode Capital Management
Boxer Capital Management
Boone Capital Management
Board of Trustees of The Leland Stanford Junior University
Perceptive Advisors

View all funds holding Kodiak Sciences